Items where Author is "Schwenkglenks, M."

2023

Aebi, N. J. and Baenteli, I. and Fink, G. and Meinlschmidt, G. and Schaefert, R. and Schwenkglenks, M. and Studer, A. and Trost, S. and Tschudin, S. and Wyss, K. and SomPsyNet Consortium, . (2023) Facilitators and barriers of routine psychosocial distress assessment within a stepped and collaborative care model in a Swiss hospital setting. PLoS One, 18 (6). e0285395.

2022

Aebi, N. J. and Fink, G. and Wyss, K. and Schwenkglenks, M. and Baenteli, I. and Caviezel, S. and Studer, A. and Trost, S. and Tschudin, S. and Schaefert, R. and Meinlschmidt, G. and SomPsyNet Consortium, . (2022) Association of different restriction levels with COVID-19-related distress and mental health in somatic inpatients: a secondary analysis of swiss general hospital data. Front Psychiatry, 13. p. 872116.

Speich, B. and Gryaznov, D. and Busse, J. W. and Gloy, V. L. and Lohner, S. and Klatte, K. and Taji Heravi, A. and Ghosh, N. and Lee, H. and Mansouri, A. and Marian, I. R. and Saccilotto, R. and Nury, E. and Kasenda, B. and Ojeda-Ruiz, E. and Schandelmaier, S. and Tomonaga, Y. and Amstutz, A. and Pauli-Magnus, C. and Bischoff, K. and Wollmann, K. and Rehner, L. and Meerpohl, J. J. and Nordmann, A. and Wong, J. and Chow, N. and Hong, P. J. and Mc Cord-De Iaco, K. and Sricharoenchai, S. and Agarwal, A. and Schwenkglenks, M. and Hemkens, L. G. and von Elm, E. and Copsey, B. and Griessbach, A. N. and Schönenberger, C. and Mertz, D. and Blümle, A. and von Niederhausern, B. and Hopewell, S. and Odutayo, A. and Briel, M.. (2022) Nonregistration, discontinuation, and nonpublication of randomized trials: a repeated metaresearch analysis. PLoS Med, 19 (4). e1003980.

Cavalli, L. and Angehrn, L. and Schindler, C. and Orsini, N. and Grob, C. and Kaufmann, M. and Steiner, L. A. and Schwenkglenks, M. and Dell-Kuster, S.. (2022) Number of comorbidities and their impact on perioperative outcome and costs - a single centre cohort study. Swiss Med Wkly, 152. w30135.

Gryaznov, D. and von Niederhäusern, B. and Speich, B. and Kasenda, B. and Ojeda-Ruiz, E. and Blümle, A. and Schandelmaier, S. and Mertz, D. and Odutayo, A. and Tomonaga, Y. and Amstutz, A. and Pauli-Magnus, C. and Gloy, V. and Lohner, S. and Bischoff, K. and Wollmann, K. and Rehner, L. and Meerpohl, J. J. and Nordmann, A. and Klatte, K. and Ghosh, N. and Taji Heravi, A. and Wong, J. and Chow, N. and Hong, P. and McCord-De Iaco, K. A. and Sricharoenchai, S. and Busse, J. W. and Agarwal, A. and Saccilotto, R. and Schwenkglenks, M. and Moffa, G. and Hemkens, L. and Hopewell, S. and Von Elm, E. and Briel, M.. (2022) Reporting quality of clinical trial protocols: a repeated cross-sectional study about the Adherence to SPIrit recommendations in Switzerland, CAnada and GErmany (ASPIRE-SCAGE). BMJ Open, 12 (5). e053417.

2021

Ulyte, Agne and Wei, Wenjia and Gruebner, Oliver and Bähler, Caroline and Brüngger, Beat and Blozik, Eva and von Wyl, Viktor and Schwenkglenks, M. and Dressel, Holger. (2021) Are weak or negative clinical recommendations associated with higher geographical variation in utilisation than strong or positive recommendations? Cross-sectional study of 24 healthcare services. BMJ Open, 11 (5). e044090.

2020

Panje, C. M. and Lupatsch, J. E. and Barbier, M. and Pardo, E. and Lorez, M. and Dedes, K. J. and Aebersold, D. M. and Plasswilm, L. and Gautschi, O. and Schwenkglenks, M. and Swiss Group for Clinical Cancer Research, . (2020) A cost-effectiveness analysis of consolidation immunotherapy with durvalumab in stage III NSCLC responding to definitive radiochemotherapy in Switzerland. Annals of Oncology, 31 (4). pp. 501-506.

Gryaznov, D. and Odutayo, A. and von Niederhausern, B. and Speich, B. and Kasenda, B. and Ojeda-Ruiz, E. and Blumle, A. and Schandelmaier, S. and Mertz, D. and Tomonaga, Y. and Amstutz, A. and Pauli-Magnus, C. and Gloy, V. and Bischoff, K. and Wollmann, K. and Rehner, L. and Lohner, S. and Meerpohl, J. J. and Nordmann, A. and Klatte, K. and Ghosh, N. and Heravi, A. T. and Wong, J. and Chow, N. and Hong, P. J. and Cord, K. M. and Sricharoenchai, S. and Busse, J. W. and Agarwal, A. and Saccilotto, R. and Schwenkglenks, M. and Moffa, G. and Hemkens, L. G. and Hopewell, S. and von Elm, E. and Briel, M.. (2020) Rationale and design of repeated cross-sectional studies to evaluate the reporting quality of trial protocols: the Adherence to SPIrit REcommendations (ASPIRE) study and associated projects. Trials, 21. p. 896.

2018

Hirschmann, A. and Lupatsch, J. E. and Schwenkglenks, M. and Panje, C. M. and Matter-Walstra, K. and Espeli, V. and Dedes, K. J. and Siano, M.. (2018) Cost-effectiveness of nivolumab in the treatment of head and neck cancer. Oral oncology, 87. pp. 104-110.

2017

Schmutz, C. and Mäusezahl, D. and Bless, P. J. and Hatz, C. and Schwenkglenks, M. and Urbinello, D.. (2017) Estimating healthcare costs of acute gastroenteritis and human campylobacteriosis in Switzerland. Epidemiology and infection, 145 (4). pp. 627-641.

2015

Matter-Walstra, K. and Achermann, R. and Rapold, R. and Klingbiel, D. and Bordoni, A. and Dehler, S. and Jundt, G. and Konzelmann, I. and Clough-Gorr, K. and Szucs, T. and Pestalozzi, B. and Schwenkglenks, M.. (2015) Cancer-Related Therapies at the End of Life in Hospitalized Cancer Patients from Four Swiss Cantons : SAKK 89/09. Oncology, 88 (1). pp. 18-27.

Schandelmaier, S. and Conen, K. and von Elm, E. and You, J. J. and Blümle, A. and Tomonaga, Y. and Saccilotto, Basel Institute for Clinical Epidemiology and Biostatistics, University Hospital of Basel and Switzerland., and Amstutz, A. and Bengough, T. and Meerpohl, J. J. and Stegert, M. and Olu, K. K. and Tikkinen, K. A. O. and Neumann, I. and Carrasco-Labra, A. and Faulhaber, M. and Mulla, S. M. and Mertz, D. and Akl, E. A. and Sun, X. and Bassler, D. and Busse, J. W. and Ferreira-González, I. and Lamontagne, F. and Nordmann, A. and Gloy, V. and Raatz, H. and Moja, L. and Rosenthal, R. and Ebrahim, S. and Vandvik, P. O. and Johnston, B. C. and Walter, M. A. and Burnand, B. and Schwenkglenks, M. and Hemkens, L. G. and Bucher, H. C. and Guyatt, G. H. and Briel, M. and Kasenda, B. and Disco study group, . (2015) Planning and reporting of quality-of-life outcomes in cancer trials. Annals of Oncology, 26 (9). pp. 1966-1973.

2014

Matter-Walstra, K. M. and Achermann, R. and Rapold, R. and Klingbiel, D. and Bordoni, A. and Dehler, S. and Jundt, G. and Konzelmann, I. and Clough-Gorr, K. and Szucs, T. and Schwenkglenks, M. and Pestalozzi, B. C.. (2014) Delivery of health care at the end of life in cancer patients of four swiss cantons : a retrospective database study (SAKK 89/09). BMC cancer, Vol. 14. pp. 306-317.

Vulsteke, C. and Pfeil, A. M. and Schwenkglenks, M. and Pettengell, R. and Szucs, T. D. and Lambrechts, D. and Peeters, M. and van Dam, P. and Dieudonné, A. S. and Hatse, S. and Neven, P. and Paridaens, R. and Wildiers, H.. (2014) Impact of genetic variability and treatment-related factors on outcome in early breast cancer patients receiving (neo-) adjuvant chemotherapy with 5-fluorouracil, epirubicin and cyclophosphamide, and docetaxel. Breast cancer research and treatment, Vol. 147, H. 3. pp. 557-570.

Matter-Walstra, K. and Klingbiel, D. and Szucs, T. and Pestalozzi, B. C. and Schwenkglenks, M.. (2014) Using the EuroQol EQ-5D in Swiss Cancer Patients, Which Value Set Should be Applied? PharmacoEconomics, Vol. 32, no. 6. pp. 591-599.

2013

Jürgens, V. and Ess, S. and Phuleria, H. C. and Früh, M. and Schwenkglenks, M. and Frick, H. and Cerny, T. and Vounatsou, P.. (2013) Tobacco-related cancer mortality : projections for different geographical regions in Switzerland. Swiss Medical Weekly, 143. w13771.

2011

Pettengell, R. and Schwenkglenks, M. and Bacon, P. and Lawrinson, S. and Duehrsen, U.. (2011) Pegfilgrastim primary prophylaxis in patients with non-Hodgkin lymphoma : results from an integrated analysis. Hematological oncology, Vol. 29, H. 4. pp. 177-184.

Szucs, T. D. and Blank, P. R. and Schwenkglenks, M. and Aapro, M.. (2011) Potential health economic impact of intravenous iron supplementation to erythropoiesis-stimulating agent treatment in patients with cancer- or chemotherapy-induced anemia. Oncology, 81 (1). pp. 45-49.

2010

Matter-Walstra, K. W. and Dedes, K. J. and Schwenkglenks, M. and Brauchli, P. and Szucs, T. D. and Pestalozzi, B. C.. (2010) Trastuzumab beyond progression: a cost-utility analysis. Annals of Oncology, 21 (11). pp. 2161-2168.

2009

Blank, P. R. and Schwenkglenks, M. and Szucs, T. D.. (2009) Disparities in influenza vaccination coverage rates by target group in five European countries : trends over seven consecutive seasons. Infection, 37. pp. 390-400.

von Minckwitz, G. and Schwenkglenks, M. and Skacel, T. and Lyman, G. H. and Pousa, A. Lopez and Bacon, P. and Easton, V. and Aapro, M. S.. (2009) Febrile neutropenia and related complications in breast cancer patients receiving pegfilgrastim primary prophylaxis versus current practice neutropaenia management : results from an integrated analysis. European journal of cancer, Vol. 45, H. 4. pp. 608-617.

McCann, S. and Schwenkglenks, M. and Bacon, P. and Einsele, H. and D'Addio, A. and Maertens, J. and Niederwieser, D. and Rabitsch, W. and Roosaar, A. and Ruutu, T. and Schouten, H. and Stone, R. and Vorkurka, S. and Quinn, B. and Blijlevens, N. and Ebmt Mucositis Advisory Group, . (2009) The Prospective Oral Mucositis Audit : relationship of severe oral mucositis with clinical and medical resource use outcomes in patients receiving high-dose melphalan or BEAM-conditioning chemotherapy and autologous SCT. Bone marrow transplantation, Vol. 43. pp. 141-147.

2008

Pettengell, R. and Schwenkglenks, M. and Bosly, A.. (2008) Association of reduced relative dose intensity and survival in lymphoma patients receiving CHOP-21 chemotherapy. Annals of hematology, Vol. 87, issue 5. pp. 429-430.

Matter-Walstra, KW. and Szucs, T. and Brauchli, P. and Schwenkglenks, M.. (2008) Randomisiert-kontrollierte Studien von Krebstherapien in der Schweiz. Outcomes Research und gesundheitsökonomische Aspekte. Schweizerische Ärztezeitung, 89 (36). pp. 1545-1549.